The COVID-19 pandemic has resulted in over 1 million fatalities in the United States, as well as a decrease in cancer screenings and diagnoses. According to studies, the drop in screenings for breast, cervical, colon, and prostate cancers during the epidemic will result in thousands more cancer deaths in the future. Star et al. analyzed data from the National Health Interview Survey, a nationally representative database, to reveal a declining trend in breast, cervical, and prostate cancer examinations across races, ethnicities, and income levels from 2019 to 2021. Colorectal cancer screenings, surprisingly, remained steady as a rise in stool-based diagnostics such as stool DNA testing countered a reduction in colonoscopies. The research emphasizes the importance of public participation.

To know more: About the original article click here.